(Q78726608)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

editorial

0 references

title

Shifting the diagnosis and treatment of atherosclerosis to children and young adults: a new paradigm for the 21st century (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1

Sotirios Tsimikas

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

author name string

Joseph L Witztum

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

language of work or name

English

0 references

publication date

1 December 2002

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

Journal of the American College of Cardiology

16 December 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

volume

40

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

page(s)

2122-2124

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

The fetal origins of atherosclerosis: maternal hypercholesterolemia, and cholesterol-lowering or antioxidant treatment during pregnancy influence in utero programming and postnatal susceptibility to atherogenesis

16 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

CORONARY DISEASE AMONG UNITED STATES SOLDIERS KILLED IN ACTION IN KOREA

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Natural history and risk factors of atherosclerosis in children and youth: the PDAY study

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Atherosclerosis of the aorta and coronary arteries and cardiovascular risk factors in persons aged 6 to 30 years and studied at necropsy (The Bogalusa Heart Study)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

High prevalence of coronary atherosclerosis in asymptomatic teenagers and young adults: evidence from intravascular ultrasound

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Endothelial dysfunction, oxidative stress, and risk of cardiovascular events in patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Prognostic impact of coronary vasodilator dysfunction on adverse long-term outcome of coronary heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Cracking down on caveolin: role of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors in modulating edothelial cell nitric oxide production

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Single LDL apheresis improves endothelium-dependent vasodilatation in hypercholesterolemic humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Endothelium-dependent coronary vasomotion relates to the susceptibility of LDL to oxidation in humans

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Immunomodulatory effects of statins: mechanisms and potential impact on arteriosclerosis

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Early statin therapy restores endothelial function in children with familial hypercholesterolemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Efficacy and safety of lovastatin in adolescent males with heterozygous familial hypercholesterolemia: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

A randomized crossover trial of combination pharmacologic therapy in children with familial hyperlipidemia

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes: the MIRACL study: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

Simvastatin and niacin, antioxidant vitamins, or the combination for the prevention of coronary disease

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

In vivo uptake of radiolabeled MDA2, an oxidation-specific monoclonal antibody, provides an accurate measure of atherosclerotic lesions rich in oxidized LDL and is highly sensitive to their regression

1 reference

https://api.crossref.org/works/10.1016%2FS0735-1097%2802%2902599-8

7 January 2021

10.1016/S0735-1097(02)02599-8

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:12505223%20AND%20SRC:MED&resulttype=core&format=json

16 December 2019

1 reference